Diane Hendricks, 10% Owner at Monopar Therapeutics (MNPR), bought 468,750 shares at $8.00 ($3.8M) on 2019-12-18, disclosed to the SEC on 2019-12-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.